SV Life Sciences Fund IV (GP), L.P.'s Net Worth

$379 Million

Estimate Recalculated Feb 16, 2024 04:30PM EST

Who is SV Life Sciences Fund IV (GP), L.P.?

SV Life Sciences Fund IV (GP), L.P. has an estimated net worth of $379 Million. This is based on reported shares across multiple companies, which include ENTELLUS MEDICAL INC, NeurogesX Inc, KalVista Pharmaceuticals, Inc., OCULAR THERAPEUTIX, INC, Ophthotech Corp., and TRANSENTERIX INC..

SEC CIK

SV Life Sciences Fund IV (GP), L.P.'s CIK is 0001422340

Past Insider Trading and Trends

2014 was SV Life Sciences Fund IV (GP), L.P.'s most active year for acquiring shares with 10 total transactions. SV Life Sciences Fund IV (GP), L.P.'s most active month to acquire stocks was the month of June. 2014 was SV Life Sciences Fund IV (GP), L.P.'s most active year for disposing of shares, totalling 52 transactions. SV Life Sciences Fund IV (GP), L.P.'s most active month to dispose stocks was the month of April. 2015 saw SV Life Sciences Fund IV (GP), L.P. paying a total of $5,399,999.00 for 3,489,531 shares, this is the most they've acquired in one year. In 2014 SV Life Sciences Fund IV (GP), L.P. cashed out on 15,227,799 shares for a total of $312,205,327.65, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENTELLUS MEDICAL INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.49M
$17.00
3.49M
Feb 3
Form 3
0
0
No matching records found

NeurogesX Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-11.90%
-300.00K
$10.25
-$3,075,000.00
2.22M
May 3
Form 4
-12.77%
-1.84M
$8.02
-$14,760,015.00
12.61M
Sep 15
Form 3
0
0
No matching records found

KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $14.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.95%
-50.00K
$29.14
-$1,460,145.18
5.2M
Apr 8 - Apr 10
Form 4
-1.77%
-97.07K
$28.27
-$2,720,896.65
5.38M
Mar 29 - Apr 2
Form 4
-2.13%
-124.67K
$28.85
-$3,596,032.21
5.73M
Mar 26 - Mar 28
Form 4
-11.65%
-262.47K
$26.70
-$7,007,949.00
1.99M
Mar 18
Form 4
-1.64%
-75.71K
$22.98
-$1,738,475.96
4.54M
Mar 4 - Mar 5
Form 4
-2.83%
-214.20K
$20.45
-$4,401,353.40
7.36M
Feb 19 - Feb 21
Form 4
-0.08%
-4.30K
$20.21
-$87,072.88
5.09M
Jan 3 - Jan 7
Form 4
-0.38%
-29.35K
$20.01
-$587,242.49
7.67M
Dec 28 - Jan 2
Form 4
-0.08%
-2.14K
$20.02
-$42,758.45
2.58M
Dec 19
Form 4
2.58M
2.58M
Nov 21
Form 3
0
0
No matching records found

OCULAR THERAPEUTIX, INC (OCUL) Snapshot price: $4.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-14.43%
-1.12M
$22.00
-$24,618,000.00
6.64M
Jun 10
Form 4
+165.24%
7.76M
$13.00
$6,199,960.00
12.45M
Jul 30
Form 3
0
0
No matching records found

Ophthotech Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.67%
-1.97M
$42.54
-$83,673,414.90
9.16M
Jun 4
Form 4
-8.70%
-1.87M
$40.40
-$75,828,246.39
19.57M
Jun 2 - Jun 3
Form 4
-4.10%
-931.87K
$41.00
-$38,201,620.47
21.8M
May 29 - May 30
Form 4
-3.98%
-980.13K
$40.11
-$39,393,644.85
23.67M
May 27 - May 28
Form 4
-1.30%
-330.45K
$37.98
-$12,590,913.00
25M
May 22 - May 23
Form 4
-12.17%
-2.11M
$29.61
-$62,517,488.04
15.24M
Feb 18
Form 4
17.35M
17.35M
Sep 30
Form 3
0
0
No matching records found